Approved Symbol |
Approved Name |
Location |
Source |
PRKCB |
protein kinase C, beta |
16p12 |
Mapped by significant region |
ACTN3 |
actinin, alpha 3 |
11q13-q14 |
Mapped by significant region |
FN1 |
fibronectin 1 |
2q34 |
Mapped by significant region |
MAPK1 |
mitogen-activated protein kinase 1 |
22q11.2 |
Mapped by LD-proxy |
SHC3 |
SHC (Src homology 2 domain containing) transforming protein 3 |
9q22.1 |
Mapped by significant region |
MYLPF |
myosin light chain, phosphorylatable, fast skeletal muscle |
16p11.2 |
Mapped by CNV |
CCND1 |
cyclin D1 |
11q13 |
Mapped by significant region |
BAD |
BCL2-associated agonist of cell death |
11q13.1 |
Mapped by significant region |
PPP1CA |
protein phosphatase 1, catalytic subunit, alpha isozyme |
11q13 |
Mapped by significant region |
PAK7 |
p21 protein (Cdc42/Rac)-activated kinase 7 |
20p12 |
Mapped by CNV |
BCAR1 |
breast cancer anti-estrogen resistance 1 |
16q22-q23 |
Mapped by significant region |
CRKL |
v-crk sarcoma virus CT10 oncogene homolog (avian)-like |
22q11.21 |
Mapped by CNV |
PDGFD |
platelet derived growth factor D |
11q22.3 |
Mapped by significant region |
ERBB2 |
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
17q11.2-q12 |
Mapped by LD-proxy |
ROCK2 |
Rho-associated, coiled-coil containing protein kinase 2 |
2p24 |
Mapped by significant region |
MAPK9 |
mitogen-activated protein kinase 9 |
5q35 |
Mapped by CNV |
TNR |
tenascin R (restrictin, janusin) |
1q24 |
Mapped by significant region |
VEGFB |
vascular endothelial growth factor B |
11q13 |
Mapped by significant region |
CAV3 |
caveolin 3 |
3p25 |
Mapped by LD-proxy; Mapped by literature SNP |
PAK1 |
p21 protein (Cdc42/Rac)-activated kinase 1 |
11q13-q14 |
Mapped by significant region |
MAPK3 |
mitogen-activated protein kinase 3 |
16p11.2 |
Mapped by CNV |
BIRC2 |
baculoviral IAP repeat containing 2 |
11q22 |
Mapped by significant region |
BIRC3 |
baculoviral IAP repeat containing 3 |
11q22 |
Mapped by significant region |
LAMC2 |
laminin, gamma 2 |
1q25-q31 |
Mapped by significant region |
TNN |
tenascin N |
1q23-q24 |
Mapped by significant region |
LAMC1 |
laminin, gamma 1 (formerly LAMB2) |
1q31 |
Mapped by significant region |
LAMA3 |
laminin, alpha 3 |
18q11.2 |
Mapped by significant region |
PIK3R1 |
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
5q13.1 |
Mapped by significant region |
TNC |
tenascin C |
9q32-q34 |
Mapped by significant region |
PIK3CG |
phosphoinositide-3-kinase, catalytic, gamma polypeptide |
7q22 |
Mapped by CNV |
ILK |
integrin-linked kinase |
11p15.4 |
Mapped by CNV |
ARHGAP5 |
Rho GTPase activating protein 5 |
14q12 |
Mapped by significant region |
FLT4 |
fms-related tyrosine kinase 4 |
5q34-q35 |
Mapped by CNV |
LAMA2 |
laminin, alpha 2 |
6q22-q23 |
Mapped by CNV; Mapped by significant region |
ITGA2 |
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) |
5q11.2 |
Mapped by LD-proxy |